By requiring Medicare to account for patient demographics as it levies penalties on hospitals for excess readmissions, the 21st Century Cures Act signed into law on Tuesday addresses long-standing demands from hospitals, but it also raises fresh concerns.
The 21st Century Cures Act signed by President Obama Tuesday has been ballyhooed as a major boost for NIH and cancer and brain research. But a closer look at the numbers reveals how little it offers—at a potentially high price.
Rumors are swirling about who President-elect Donald Trump may choose to lead the Food and Drug Administration, including a venture capitalist and a former agency official.
The Senate's passage of the 21st Century Cures bill Wednesday reflects something of a mixed bag for public health advocates.
President Barack Obama is expected to sign the massive lame-duck legislation that affects almost every corner of the healthcare industry.
The sweeping legislation passed the House last week and President Barack Obama has said he intends to sign it as soon as it reaches his desk.
Congress took an important first step in improving the nation's struggling system of care for millions of Americans suffering from mental illness and drug addiction by including a sweeping package of mental healthcare and addiction treatment reforms as part of the 21st Century Cures Act.
On the surface, it looks like every healthcare special interest and their 1,400 lobbyists won an early Christmas present courtesy of the 21st Century Cures Act, which passed the House of Representatives by a whopping 392-26 margin last week and appears headed for Senate passage and enactment.
Many Americans are wondering about the future of healthcare in our country following the recent elections at the federal, state and local levels. It's too soon to know how events will unfold, but one thing is clear.
The 21st Century Cures Act last week received cheers from virtually every segment of the healthcare industry. The bill appears headed for quick Senate passage and signature into law by President Barack Obama.
The 21st Century Cures Act, which overwhelmingly passed the House last week, opens new avenues for companies to win quicker FDA approval. It continues to draw fire from safety advocates and worried payers, who foot the bill for expensive new therapies.
The agency won't regulate software "for administrative support of a healthcare facility." That includes financial records, information about patient populations, and a number of consumer-facing applications, including those for “maintaining and encouraging a healthy lifestyle.”